AccessPak for HIV PEP Expanded with Kaletra and RespiVent Dosepack DF
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and RespiVent Dosepack DF and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: chlorpheniramine / methscopolamine
Brand name:
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Restall
- AccessPak for HIV PEP Expanded with Kaletra-Restoril
- AccessPak for HIV PEP Expanded with Kaletra-Retacrit
- AccessPak for HIV PEP Expanded with Kaletra-Retapamulin
- AccessPak for HIV PEP Expanded with Kaletra-Retapamulin topical
- AccessPak for HIV PEP Expanded with Kaletra-Retapamulin Topical application
- RespiVent Dosepack DF-AccessPak for HIV PEP Expanded with Viracept
- RespiVent Dosepack DF-Accolate
- RespiVent Dosepack DF-Accretropin
- RespiVent Dosepack DF-Accucaine
- RespiVent Dosepack DF-AccuHist Drops
- RespiVent Dosepack DF-AccuHist PDX Drops